0000899243-20-014545.txt : 20200529 0000899243-20-014545.hdr.sgml : 20200529 20200529160907 ACCESSION NUMBER: 0000899243-20-014545 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200527 FILED AS OF DATE: 20200529 DATE AS OF CHANGE: 20200529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knudson Susan A. CENTRAL INDEX KEY: 0001624925 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36003 FILM NUMBER: 20927766 MAIL ADDRESS: STREET 1: 9191 TOWNE CENTRE DRIVE, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Histogen Inc. CENTRAL INDEX KEY: 0001383701 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203183915 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: SUITE 250 CITY: San Diego STATE: CA ZIP: 92127 BUSINESS PHONE: (858) 376-2600 MAIL ADDRESS: STREET 1: 16745 WEST BERNARDO DRIVE STREET 2: SUITE 250 CITY: San Diego STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc. DATE OF NAME CHANGE: 20140729 FORMER COMPANY: FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc DATE OF NAME CHANGE: 20061214 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-05-27 1 0001383701 Histogen Inc. HSTO 0001624925 Knudson Susan A. C/O HISTOGEN INC. 10655 SORRENTO VALLEY RD., STE 200 SAN DIEGO CA 92121 0 1 0 0 See Remarks Executive Vice President & Chief Financial Officer /s/ Richard W. Pascoe, as attorney-in-fact for Susan A. Knudson 2020-05-29 EX-24 2 attachment1.htm EX-24 DOCUMENT
                               POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints
each of Thomas L. Hubka and Richard W. Pascoe, signing singly, the undersigned's
true and lawful attorney-in-fact to:

     (1)  prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a
Form ID, including any amendments thereto, and any other documents necessary or
appropriate to obtain codes and passwords enabling the undersigned to make
electronic filings with the SEC of reports required by Section 16(a) of the
Securities Exchange Act of 1934, as amended (together with the rules and
regulations of the SEC promulgated thereunder, the "Exchange Act");

     (2)  execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer of the Histogen Inc. (the "Company") or its subsidiaries,
Forms 3, 4 and 5 in accordance with Section 16(a) of the Exchange Act;

     (3)  do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form 3, 4
or 5, complete and execute any amendment or amendments thereto, and timely file
such form with the SEC and any stock exchange or similar authority; and

     (4)  take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until the earliest
to occur of:  (i) the date the undersigned is no longer required to file Forms
3, 4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company; and (ii) the revocation hereof by the
undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
This Power of Attorney revokes all prior Powers of Attorney relating to
reporting under Section 16 of the Exchange Act of holdings of and transactions
in the Company's securities.

This Power of Attorney may be executed by electronic signature (including any
electronic signature complying with the ESIGN Act of 2000, such as
www.docusign.com) and/or delivered by electronic transmission, including by
facsimile or electronic mail, and when so executed and/or delivered shall have
been duly and validly executed and/or delivered, and be valid and effective, for
all purposes.

                         [ the signature page follows ]


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 29 day of May, 2020.


                                             /s/  Susan A. Knudson
                                        ------------------------------------
                                             Name: Susan A. Knudson